| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |